Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Massimo Cristofanilli

Showing results (51-60 of 438) with videos related to

Pageof 44
Sort By:
The New England Journal of Medicine|February 21, 2019
Palbociclib and Fulvestrant in Breast Cancer. ReplyNicholas C Turner, Xin Huang, Massimo Cristofanilli
Nature Reviews. Clinical Oncology|October 20, 2010
Molecular mechanisms of metastasis in breast cancer--clinical applicationsMichal Mego, Sendurai A Mani, Massimo Cristofanilli
The New England Journal of Medicine|May 5, 2007
A gene signature in breast cancerWendy A Woodward, Anthony Lucci, Massimo Cristofanilli
Chinese Journal of Cancer Research = Chung-Kuo Yen Cheng Yen Chiu|January 30, 2013
Circulating tumor cells (CTCs) in breast cancer: a diagnostic tool for prognosis and molecular analysisXiaoshen Dong, Katherine R Alpaugh, Massimo Cristofanilli
Seminars in Oncology|March 1, 2008
The medical treatment of inflammatory breast cancerShaheenah Dawood, Naoto T Ueno, Massimo Cristofanilli
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 15, 2004
Inflammatory breast carcinoma: the sphinx of breast cancer researchMassimo Cristofanilli, Eva S Singletary, Gabriel N Hortobagyi
The New England Journal of Medicine|October 22, 2015
Palbociclib in Hormone-Receptor-Positive Advanced Breast CancerNicholas C Turner, Cynthia Huang Bartlett, Massimo Cristofanilli
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 2005
Inflammatory breast cancer and high-dose chemotherapy: back to the pastAna Maria Gonzalez-Angulo, Paolo Morandi, Massimo Cristofanilli
Annals of Translational Medicine|December 10, 2014
CTC enumeration and characterization: moving toward personalized medicineAngela Toss, Zhaomei Mu, Sandra Fernandez, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 20, 2008
Risk of ipsilateral lung cancer after postmastectomy radiotherapy and smoking: does the possible triumph over the actual?Ugo De Giorgi, George H Perkins, Massimo Cristofanilli
Pageof 44

Showing results (51-60 of 438) with videos related to

Sort By:
Pageof 44
The New England Journal of Medicine|February 21, 2019
Palbociclib and Fulvestrant in Breast Cancer. ReplyNicholas C Turner, Xin Huang, Massimo Cristofanilli
Nature Reviews. Clinical Oncology|October 20, 2010
Molecular mechanisms of metastasis in breast cancer--clinical applicationsMichal Mego, Sendurai A Mani, Massimo Cristofanilli
The New England Journal of Medicine|May 5, 2007
A gene signature in breast cancerWendy A Woodward, Anthony Lucci, Massimo Cristofanilli
Chinese Journal of Cancer Research = Chung-Kuo Yen Cheng Yen Chiu|January 30, 2013
Circulating tumor cells (CTCs) in breast cancer: a diagnostic tool for prognosis and molecular analysisXiaoshen Dong, Katherine R Alpaugh, Massimo Cristofanilli
Seminars in Oncology|March 1, 2008
The medical treatment of inflammatory breast cancerShaheenah Dawood, Naoto T Ueno, Massimo Cristofanilli
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 15, 2004
Inflammatory breast carcinoma: the sphinx of breast cancer researchMassimo Cristofanilli, Eva S Singletary, Gabriel N Hortobagyi
The New England Journal of Medicine|October 22, 2015
Palbociclib in Hormone-Receptor-Positive Advanced Breast CancerNicholas C Turner, Cynthia Huang Bartlett, Massimo Cristofanilli
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 2005
Inflammatory breast cancer and high-dose chemotherapy: back to the pastAna Maria Gonzalez-Angulo, Paolo Morandi, Massimo Cristofanilli
Annals of Translational Medicine|December 10, 2014
CTC enumeration and characterization: moving toward personalized medicineAngela Toss, Zhaomei Mu, Sandra Fernandez, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 20, 2008
Risk of ipsilateral lung cancer after postmastectomy radiotherapy and smoking: does the possible triumph over the actual?Ugo De Giorgi, George H Perkins, Massimo Cristofanilli
Pageof 44